Key Points
Lagevrio COVID-19 oral antiviral treatments for little or no cost even after the U.S. government starts handing over their distribution to the commercial market next month, health officials said on Friday...
"The launch of these products, which is what's going to happen on Nov. 1, is not going to bring sudden changes because there's still an ample supply of federally-owned therapeutics with millions of treatment courses still in the field," said a U.S. Department of Health and Human Services (HHS) official...
Providers will be able to order government-supplied Lagevrio until Nov. 10 and Paxlovid until Dec. 15, the official said, and the government is encouraging them to keep distributing the federal-owned supply they have at no cost until it expires or runs out...
Under an agreement with Pfizer allowing the return of 7.9 million courses, the credits for the returned doses will underwrite a program keeping Paxlovid free of charge for patients insured under the Medicare and Medicaid programs through the end of 2024, and to uninsured and underinsured patients through 2028, the official said.. Returns will begin on Nov. 15, the official said, and will be accepted through the end of the year..
You might be interested in
US to shift Covid antivirals to commercial market from November
28, Oct, 23US health officials confirmed that most people will continue to have access to Pfizer's Paxlovid and Merck's Lagevrio COVID-19 oral antiviral treatments at little or no cost, even as the distribution of these treatments transitions to commercial market next month.
Singapore seeing new Covid wave, warns health minister; daily cases reach 2,000
06, Oct, 23The spate of these recent Covid cases is driven by mostly two variants - the EG.5 and its sub-lineage HK.3. | World News